These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 638027)

  • 1. Myocardial changes after infection with Coxsackie virus B3 in nude mice.
    Hashimoto I; Komatsu T
    Br J Exp Pathol; 1978 Feb; 59(1):13-20. PubMed ID: 638027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of T lymphocytes in the pathogenesis of Coxsackie virus B3 heart disease.
    Hashimoto I; Tatsumi M; Nakagawa M
    Br J Exp Pathol; 1983 Oct; 64(5):497-504. PubMed ID: 6315043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of replicating coxsackievirus B3 in the athymic murine heart is associated with development of myocarditic lesions.
    Sato S; Tsutsumi R; Burke A; Carlson G; Porro V; Seko Y; Okumura K; Kawana R; Virmani R
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():2911-24. PubMed ID: 7964602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coxsackievirus B3 persistence and myocarditis in N:NIH(S) II nu/nu and +/nu mice.
    Schnurr DP; Cao Y; Schmidt NJ
    J Gen Virol; 1984 Jul; 65 ( Pt 7)():1197-201. PubMed ID: 6747601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo significance of T cells in the development of Coxsackievirus B3 myocarditis in mice. Immature but antigen-specific T cells aggravate cardiac injury.
    Kishimoto C; Abelmann WH
    Circ Res; 1990 Sep; 67(3):589-98. PubMed ID: 1697791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell-mediated immune response enhances the severity of myocarditis in secondary cardiotropic virus infection in mice.
    Kishimoto C; Hiraoka Y; Takada H
    Basic Res Cardiol; 2001 Sep; 96(5):439-45. PubMed ID: 11605990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of pre-existing coxsackievirus B4 myocardial disease on the expression of coxsackievirus B3 myocarditis.
    Khatib R; Reyes MP; Khatib G; Giraldo A
    Can J Cardiol; 1993 Jun; 9(5):444-7. PubMed ID: 8394194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental coxsackie B virus myocarditis in mice: 18 month histopathological and virological study.
    Kutaura Y
    Jpn Circ J; 1981 Jul; 45(7):747-62. PubMed ID: 6267334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-perforin neutralizing antibody reduces myocardial injury in viral myocarditis.
    Chun-yan G; Bo H; Hong C; Hong-lei J; Xiu-zhen H
    Cardiol Young; 2009 Dec; 19(6):601-7. PubMed ID: 19825252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal changes in stem cells in the circulation and myocardium of mice with Coxsackie virus B3-induced myocarditis.
    Zhao L; Li S; Ge J; Sun A; Zou Y; Zhang S
    Microvasc Res; 2008 Apr; 75(3):358-66. PubMed ID: 18206181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trace element distribution in heart tissue sections studied by nuclear microscopy is changed in Coxsackie virus B3 myocarditis in methyl mercury-exposed mice.
    Ilbäck NG; Lindh U; Wesslén L; Fohlman J; Friman G
    Biol Trace Elem Res; 2000; 78(1-3):131-47. PubMed ID: 11314973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of FK-506, a novel and potent immunosuppressant, upon murine Coxsackievirus B3 myocarditis.
    Hiraoka Y; Kishimoto C; Kurokawa M; Ochiai H; Sasayama S
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1386-91. PubMed ID: 1372051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the pathogenesis of atrial myocarditis in mice infected with Coxsackie virus B3.
    Hashimoto I; Hagiwara A
    Br J Exp Pathol; 1986 Feb; 67(1):43-53. PubMed ID: 3947534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of T cells in mouse cytomegalovirus myocarditis.
    Lawson CM; O'Donoghue H; Reed WD
    Immunology; 1989 May; 67(1):132-4. PubMed ID: 2544512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coxsackievirus B3 persistence and myocarditis in NFR nu/nu and +/nu mice.
    Schnurr DP; Schmidt NJ
    Med Microbiol Immunol; 1984; 173(1):1-7. PubMed ID: 6088960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a murine model of myocarditis induced by a reactivated coxsackievirus B3.
    Zhang H; Yousef GE; Ouyang X; Archard LC
    Int J Exp Pathol; 1994 Apr; 75(2):99-110. PubMed ID: 8199011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine natural killer cells limit coxsackievirus B3 replication.
    Godeny EK; Gauntt CJ
    J Immunol; 1987 Aug; 139(3):913-8. PubMed ID: 3036947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coxsackievirus B 1-induced polymyositis. Lack of disease expression in nu/nu mice.
    Ytterberg SR; Mahowald ML; Messner RP
    J Clin Invest; 1987 Aug; 80(2):499-506. PubMed ID: 3038960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental Coxsackie virus B-3 and B-4 myocarditis in mice.
    Kawai C; Matsumori A; Kumagai N; Tokuda M
    Jpn Circ J; 1978 Jan; 42(1):43-7. PubMed ID: 633597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine profiles in heart, spleen, and thymus during the acute stage of experimental coxsackievirus B3-induced chronic myocarditis.
    Schmidtke M; Glück B; Merkle I; Hofmann P; Stelzner A; Gemsa D
    J Med Virol; 2000 Aug; 61(4):518-26. PubMed ID: 10897072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.